8-K 1 e8-k.txt ZONAGEN, INC. - DATED JULY 27, 2000 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Filed Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2000 ZONAGEN, INC. (Exact name of registrant as specified in its charter) Delaware 0-21198 76-0233274 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer Identification No.) incorporation or organization)
2408 Timberloch Place, Suite B-4 The Woodlands, Texas 77380 (Address of principal executive offices and zip code) (281) 719-3400 (Registrant's telephone number, including area code) 2 Item 5. Other Events On July 27, 2000, Zonagen, Inc. issued a press release announcing its decision to seek strategic alternatives and to reduce expenditures as a result of the regulatory delay of VASOMAX(TM). The action will result in the dismissal of more than one-half of the Company's work force. The press release is filed as an exhibit to this Current Report on Form 8-K and is incorporated by reference herein. Item 7. Exhibits Exhibit 99.1 -- Press Release dated July 27, 2000. 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZONAGEN, INC. Date: August 8, 2000 By: /s/ Louis Ploth, Jr. ------------------------------- Louis Ploth, Jr. Vice President, Finance 3 4 EXHIBIT INDEX ---------------- Exhibit No. ----------- 99.1 Press Release dated July 27, 2000.